Dr Mike Jones – Managing Director – Impact Minerals (ASX:IPT) is an exploration company listed on the ASX in November 2006. The Company manages extensive tenement holdings (>4,000 km2) within Australia featuring significant potential for high-grade mineral deposits of gold, silver, lead, zinc, copper, nickel and PGM’s.
Copyright 2023 – Finance News Network
Source: Finance News Network
13 Feb 2020 - Centuria Capital Group (ASX:CNI) Joint CEO, John McBain talks 1H20 results & outlook, including the contribution from recent acquisitions as group AUM now exceeds $7.3B.
Read More26 Aug 2024 - BluGlass Limited (ASX:BLG) CEO Jim Haden discusses the company's record quarter, IP deals, customer engagement and the upcoming Semiconductor Australia conference.
Read More16 Oct 2024 - Rita Gatt, National Lead Partner - Regulation, Security and Risk at Deloitte, discusses the revolutionary potential of quantum computing.
Read More29 Aug 2025 - Expanding technology and market reach
Read More07 Apr 2025 - The Final Steps in Drug Development and Market Access
Read More08 Nov 2023 - Anax Metals (ASX:ANX) CEO, Geoff Laing, discusses the company's flagship Whim Creek Copper Hub, emphasizing its innovative approach and rapid path to production. The conversation delves into scalability, lithium exploration potential, and strategic partnerships, offering insights into Anax Metals' ambitious vision for resource development and polymetallic ventures.
Read More13 Apr 2023 - Newmark Capital Managing Director Chris Langford discusses the group's portfolio, investment philosophy, results, strategy, the recent share buyback, and the outlook for the REIT sector.
Read More29 Jul 2021 - BARD1 Life Sciences Limited (ASX:BD1) CEO Dr Leearne Hinch introduces the company, discussing its recent capital raising and share purchase plan.
Read More21 Feb 2023 - BluGlass Limited (ASX:BLG) President Jim Haden provides an update on the company, discussing the launch of the company's first suite of laser products, integration of the recently acquired fab facility and outlook for 2023.
Read More18 Dec 2019 - Oventus Medical Limited (ASX:OVN) Managing Director and CEO, Dr Chris Hart talks about the company's North American sales process via its lab in lab model and how this improves patient outcomes.
Read More
